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Abstract
Background—Improving predictive accuracy is of paramount importance for early detection 
and prevention of psychosis. We sought a symptom severity classifier that would improve 
psychosis risk prediction.
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Methods—Subjects were from two cohorts of the North American Prodrome Longitudinal 
Study. All subjects met Criteria of Psychosis-Risk States. In Cohort-1 (n=296) we developed a 
classifier that included those items of the Scale of Psychosis-Risk Symptoms that best 
distinguished subjects who converted to psychosis from nonconverters, with performance initially 
validated by randomization tests in Cohort-1. Cohort-2 (n=592) served as an independent test set.
Results—We derived 2-Item and 4-Item subscales. Both included unusual thought content and 
suspiciousness; the latter added reduced ideational richness and difficulties with focus/
concentration. The Concordance Index (C-Index), a measure of discrimination, was similar for 
each subscale across cohorts (4-Item subscale Cohort-2: 0.71, 95%CI=[0.64,0.77], Cohort-1: 0.74, 
95%CI=[0.69,0.80]; 2-Item subscale Cohort-2: 0.68, 95%CI=[0.3,0.76], Cohort-1: 0.72, 
95%CI=[0.66-0.79]). The 4-Item performed better than the 2-Item subscale in 742/1000 random 
selections of 80% subsets of Cohort-2 subjects (p-value=1.3E-55). Subscale calibration between 
cohorts was proportional (higher scores/lower survival), but absolute conversion risk predicted 
from Cohort-1 was higher than that observed in Cohort-2, reflecting the cohorts’ differences in 2-
year conversion rates (Cohort-2: 0.16, 95%CI=[0.13,0.19]; Cohort-1: 0.30, 95%CI=[0.24,0.36]).
Conclusion—Severity of unusual thought content, suspiciousness, reduced ideational richness, 
and difficulty with focus/concentration informed psychosis risk prediction. Scales based on these 
symptoms may have utility in research and, assuming further validation, eventual clinical 
applications.
Keywords
psychosis; high-risk; risk prediction; symptom severity; schizophrenia; survival
Introduction
Development of preventative interventions for schizophrenia requires identifying persons at 
very high risk. An early study examining psychosis conversion in persons meeting high-risk 
diagnostic criteria reported a 45% 2-year conversion rate (Yung et al., 2004), however 
subsequent studies found 2-year conversion rates that ranged from 15-30% (Demjaha et al., 
2012; DeVylder et al., 2014; Katsura et al., 2014; Lee et al., 2014; Liu et al.; Nelson et al., 
2013; Riecher-Rossler et al., 2009; Ruhrmann et al., 2010; Woods et al., 2009; Ziermans et 
al., 2011). Efforts are needed to improve psychosis risk prediction.
Prominent among the scales used to evaluate symptoms associated with psychosis risk is the 
Scale of Psychosis-Risk Symptoms (SOPS) (McGlashan et al., 2010; Miller et al., 2002). 
The SOPS comprises 19 symptoms in four domains that include: positive (unusual thought 
content/delusional ideas, suspiciousness/persecutory ideas, grandiose ideas, perceptual 
abnormalities/hallucinations, disorganized communication), negative (social anhedonia, 
avolition, decreased expression of emotion, decreased experience of emotions and self, 
reduced ideational richness, reduced occupational functioning), disorganized (odd behavior 
or appearance, bizarre thinking, trouble with focus and attention, impaired hygiene), and 
general (sleep disturbance, dysphoric mood, motor disturbances, impaired stress tolerance). 
The symptoms evaluated by the SOPS were chosen to reflect broadly the symptoms 
experienced by persons with schizophrenia during their prodrome.
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We sought to identify among items measured by the SOPS subsets that best predicted 
psychosis conversion. We considered two large independent cohorts, the North American 
Prodrome Longitudinal Study Cohort-1 and the North American Prodrome Longitudinal 
Study Cohort-2. This allowed construction of risk prediction subscales in Cohort-1 and 
evaluation of subscale performance in Cohort-2.
Methods
1_Subjects
Detailed study methods were reported previously (Addington et al., 2007; Addington et al., 
2012; Cannon et al., 2008). In brief, the North American Prodrome Longitudinal Study is a 
multisite observational study of the predictors and mechanisms of conversion to psychosis in 
persons meeting Criteria of Psychosis-Risk Syndromes (COPS) (Miller et al., 2003). There 
were two non-overlapping waves of recruitment, Cohort-1 and Cohort-2. For Cohort-1 a 
database combined the results post hoc from eight independent studies that used a 
prospective design and similar ascertainment and rating methods (Addington et al., 2007). 
Cohort-2 was developed as a 2-year prospective collaboration of the same eight sites 
(Addington et al., 2012). For both cohorts, subjects’ ages ranged from 12 to 35. Studies were 
approved by the sites’ Institutional Review Boards, and subjects provided written informed 
consent or assent, with a parent/guardian consenting for persons under age 18.
Study participants were evaluated using the Structured Interview for Psychosis-Risk 
Syndromes (SIPS) (McGlashan et al., 2010; Miller et al., 2002) to determine if they met 
criteria for one or more of the following high-risk syndromes: attenuated psychotic 
symptoms syndrome; brief intermittent psychotic symptoms syndrome; and genetic risk and 
deterioration syndrome. The Presence of Psychosis (POP) criteria (McGlashan et al., 2010; 
Miller et al., 2002) were used to classify a subject as a “converter” to psychosis (see 
Supplement for detailed criteria). For subjects who converted, date of conversion was 
estimated by clinical interview and, if available, medical records. Diagnostic and Statistical 
Manual IV (First, 2002) (DSM-IV) psychotic disorder diagnosis was based on Structured 
Clinical Interview for DSM IV (First, 2002) performed by trained raters. Subjects were re-
assessed every six months by raters. While symptom severity was assessed at baseline, prior 
to conversion, study raters had access to baseline ratings when evaluating conversion status. 
There is a possibility that this knowledge could have impacted assessment of conversion. To 
protect against possible bias all high-risk subjects were reviewed at study entry and at 
conversion by experts (JA and TM) during a diagnostic conference call, to ensure that 
criteria were met.
The severity of symptoms was scored on the Scale of Psychosis-risk Symptoms (SOPS) 
(McGlashan et al., 2010) as follows: 0 =absent; 1=questionably present; 2=mild; 
3=moderate; 4=moderately severe; 5=severe but not psychotic; and 6=severe and psychotic. 
To simplify analysis, we rescored mild and questionably present from “1” or “2” to “0”. We 
rescored the threshold severity as follows: “moderate” as “1”; “moderately severe” as “2”; 
“severe but not psychotic” as “3”; and “severe and psychotic” as “4”. Applying our analysis 
strategy to the original scale had no effect on choice of informative symptoms.
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For Cohort-1, raters at each site were trained by the instrument’s developers and achieved 
high inter-rater reliability for high-risk syndrome diagnoses (kappa >0.80) (Addington et al., 
2007; Cannon et al., 2008). In addition several sites participated in an evaluation of 
symptom scoring reliability, achieving intra-class coefficients of > 0.7 for each item (Miller 
et al., 2003). For Cohort-2, raters were required to have yearly assessments; intraclass 
correlation coefficients for the SOPS total and positive subscales were required to be >0.8 
(Addington et al., 2012).
We excluded from this report subjects who did not meet Criteria of Psychosis-Risk States, 
who had no follow-up visits, or who had items missing from the baseline SOPS (Figure 1). 
The follow-up period for survival analysis was two years (the duration of systematic follow-
up for Cohort-2).
2_Statistical Methods
2.1 Classifier Development—We sought a “risk prediction subscale” for the SOPS, 
meaning a sum of chosen items that best identified high-risk subjects who subsequently 
developed psychosis. We used a simple “greedy algorithm” (Comen et al., 2009; Liu et al., 
2005) that first finds the best single item relative to a specified metric. Then, if possible, it 
finds a second item that, when added to the first, most improves the metric, and so on. The 
algorithm terminates when no additional items improve the metric. Classifier development 
implemented the greedy algorithm using five-fold cross validation (Kohavi, 1995) with 
Excel macros and add-ins (Moons et al., 2012). We excluded a random 25% of the subjects 
from each group, then randomly partitioned the remaining subjects each into five nearly 
equal subsets. Four converter and four nonconverter subsets were selected and the algorithm 
applied to all of the 25 possible combinations of converter and nonconverter subsets. We 
then randomly re-partitioned the five subsets and repeated the symptom selection process, a 
total of 20 times, resulting in 500 trials. We then excluded a new random 25% of subjects, 
and then repeated the entire process 10 times, thus generating 5000 total trials. As each 
model was built ab initio from subsets of the data, the derived classifiers were not identical. 
There is a wealth of literature on the merits of various model-building strategies (Hand, 
2006; Harrell et al., 1984; Harrell et al., 1996; Kohavi, 1995) but less guidance on strategies 
to best integrate the multiple derived classifiers. Our approach was to rank the symptoms by 
their selection frequencies, with the most frequently selected items forming the integrated 
classifiers.
As part of the classifier development phase (Cohort-1) we used a randomization test (Fisher, 
(1971) [1935]) to determine whether the derived subscales actually performed better than 
chance. We did so because modern algorithms are capable of finding patterns even in 
randomized data due to hidden interrelationships. The area under the curve (AUC) of the 
receiver operating characteristic (ROC) is a plot of sensitivity (predicted positives/true 
positives) and 1-specificity (predicted negatives/true negatives), at each possible cut-off 
point for the scale score. From samples of real data, the typical AUC can be in excess of 0.5, 
although 0.5 is the expected null value from random classification using prior probability 
(Rucker et al., 2007). A randomization test requires that pseudo-classifiers are constructed 
ab initio from pseudo-data with exactly the same algorithm used for true data (Buzkova et 
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al., 2011; Lindgren et al., 1996; Rucker et al., 2007; Smit et al., 2008; Tropsha, 2010). 
Applying this process 1000 times to Cohort-1 data, we created pseudo-data by randomly 
assigning subjects to pseudo-groups of “converted” or “nonconverted,” preserving original 
group sizes. Exactly the same classifier construction process as above was applied to the 
pseudo-data to yield 1000 pseudo-classifiers.
2.2 Survival Analysis—Validation was done with survival analyses using R version 
3.1.2. We used two related measures to evaluate discrimination (Heagerty and Zheng, 2005). 
To evaluate the ability of the prediction model to order the survival time we used the 
Concordance Index (C-index) (Pencina and D'Agostino, 2004); and to order the survival 
status (converter/nonconverter) the AUC (Blanche et al., 2013). Both the C-Index and the 
AUC range from 0.5 (no predictive ability)-1.0 (perfect predictive ability). The success rate 
difference (SRD) is the difference in conversion rates for subjects at high and low risk as 
determined at a specified cut-off value for the scale, thus ranging from 0-1 (Kraemer and 
Kupfer, 2006). As a measure of utility we used the Number Needed to Take (NNT) 
(analagous to the more familiar “Number Needed to Treat”, a utility measure often used in 
clinical trials); note that NNT=1/SRD (Kraemer and Kupfer, 2006). The NNT indicates how 
many persons need to be identified as high-risk to detect one conversion more than that seen 
in the low-risk group. The calibration plot, a scatterplot of the Kaplan-Meier survival 
estimates at different classifier cutoff points, compares scaling of the classifiers in the two 
cohorts.
Results
3.1 Study subjects (Table 1)
Baseline evaluations for Cohort-1 occurred in 1998-2005 and for Cohort-2 in 2008-2013. 
Compared to included subjects, excluded subjects had significantly lower parental education 
in both cohorts. For Cohort-1, the diagnosis at conversion was known for 59 (66%): Bipolar 
Disorder (n=6), Brief Psychotic Disorder (n=2), Delusional Disorder (n=2), Psychosis NOS 
(n=16), Schizoaffective Disorder (n=6), Schizophrenia (n=15), and Schizophreniform 
Disorder (n=12). For Cohort-2, the diagnosis at conversion was known for 78 (85%): 
Bipolar Disorder (n=7), Brief Psychotic Disorder (n=2), Delusional Disorder (n=3), 
Psychosis NOS (n=31), Schizoaffective Disorder (n=5), Schizophrenia (n=18), and 
Schizophreniform Disorder (n=12).
3.2 Classifier development
The greedy algorithm was run repeatedly on randomly chosen subsets of converters and 
nonconverters. With each run, somewhat different combinations of symptoms were chosen 
(Figure 2). We observed greedy algorithm termination after choosing an average of 5.9 
symptoms (of 19) (sd = 0.85). Suspiciousness/persecutory ideas (P2) and unusual thought 
content (P1) and were chosen in almost all trials followed by reduced ideational richness 
(N5) and trouble with focus and attention (D3). (See Supplement for detailed descriptions of 
these symptoms.) Considering Figure 2, we defined a 2-Item subscale classifier as the sum 
of the two most frequently selected symptoms (P1,P2) and a 4-Item subscale as the sum of 
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the four most frequently selected symptoms (P1,P2,N5,D3). The same four were also first 
selected when the greedy algorithm was applied to the full data.
3.3 Validation of Classifier Development Methods in Cohort-1
Computer-implemented classifier methods can find seemingly robust patterns in random 
data, but the AUCs of random data should be low compared to the AUC of a classifier built 
with true data. We applied exactly the same greedy algorithm to data where converter/
nonconverter group membership was randomly reassigned and calculated the resulting 
AUC. The AUCs of each pseudo-classifier applied to its pseudo-data were summarized in a 
histogram and fitted with a beta distribution (Figure 3). The AUC of the true 4-Item subscale 
applied to Cohort-1 was 0.74 with a parametric p-value relative to the distribution of 3.9E-5. 
Alternatively, since in exactly one of the 1000 trials, the pseudo-classifier AUC was by 
chance better than the true AUC, a nonparametric p-value is (1+1)/(1000+1)=2.0E-3.
3.4 Independent testing of classifier performance in Cohort-2
Cohort-2 baseline conversion rates at all time-points were less than those of Cohort-1 
(Cannon et al., 2008; Woods et al., 2009)] (Figure 4).
In Cohort-2 discrimination, as evaluated with the C-Index, was consistently higher with the 
4-Item than with the 2-Item subscale at all follow-up time points (Supplement, Figure S1). 
At 2-years the C-Index for the 4-Item subscale was greater than the 2-Item subscale for 743 
of 1000 trials of 80% (with replacement) randomly chosen subsets of subjects (p-
value=1.3E-55). In Cohort-2 at 2-years the 4-Item subscale was greater than the SOPS Total 
in 968 of 1000 trials, and the 2-Item subscale greater than the SOPS Total in 883 of 1000 
trials (p-values<1.3E-55).
Using an optimized cut-off, the conversion rates over time were significantly higher for 
persons declared “high-risk” compared to persons compared “low-risk” at times 6, 12, 18 
and 24 months (Figure 4). The AUCs did not vary substantially over time.
Calibration curves compared scaling with a graph of the Kaplan-Meier survival (herein 
nonconversion) proportions at 6, 12, 18, and 24 months, with values from Cohort-1 
(predicted) on the x-axis and Cohort-2 (observed) on the y-axis (Figure 5). The Pearson R2 
values, reported in the Figure legends for each time period, were all above 0.9, indicating 
that higher subscale scores predicted lower survival proportionally in Cohort-1 and 
Cohort-2. Miscalibration-in-the-large was apparent, however, related to the higher survival 
rates seen in Cohort-2 relative to Cohort-1.
Discussion
The performance of the 2-Item subscale indicates that the severity of unusual thought 
content (P1), referential thinking (both P1,P2) and suspiciousness (P2) are key high-risk 
symptoms. The majority of published studies examining symptoms and risk prediction 
likewise have reported that items reflecting disordered thought content (unusual ideas 
(Katsura et al., 2014; Nelson et al., 2013; Salokangas et al., 2013; Thompson et al., 2013; 
Thompson et al., 2011; Wilcox et al., 2014), suspiciousness (Riecher-Rossler et al., 2009; 
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Salokangas et al., 2013; Wilcox et al., 2014), bizarre thoughts (Ruhrmann et al., 2010), odd 
beliefs/magical thinking (Mason et al., 2004), problems distinguishing fantasy and reality 
(Klosterkotter et al., 2001), unstable ideas of reference (Klosterkotter et al., 2001), 
derealization (Klosterkotter et al., 2001)) are more severe in converters than nonconverters; 
this is despite variations in: diagnostic criteria for clinical high-risk; instruments to measure 
symptom severity; and study populations (Schultze-Lutter et al., 2013) (Supplement, Table 
S1). It is important to note that our reported performance of the subscales applied to persons 
meeting Criteria of Psychosis-Risk States, and may be different in persons meeting other 
high-risk diagnostic criteria.
Discrimination with the 4-Item subscale was, with certainty, better than that of the 2-Item 
subscale; however, the magnitude of this difference was small, implying clinical importance 
is yet to be determined. The 4-Item subscale (and the 2-Item subscale) also performed better 
than the SOPS Total. However, we do not claim to have found optimal or unique 
combinations of symptoms for psychosis risk prediction. Furthermore, there may be high-
risk subtypes better predicted by different symptoms.
There is further reason to continue to consider the two additional items in future studies. The 
additional items reflect disturbances of thought process. N5 (reduced ideational richness) is 
defined in the SOPS as having difficulties in: following everyday conversations; making 
sense of familiar phrases; grasping the gist of conversations; escaping patterns of repetitious 
or simplistic thought content; considering alternative positions; shifting ideas; using 
anything but simplistic language; and thinking abstractly. D3 (trouble with focus and 
attention) includes difficulties in: maintaining focused attention and resisting distraction due 
to internal and external stimuli; holding conversations in memory; and executing other 
short-term memory tasks. Other investigators have predicted psychosis risk from disordered 
thought processes including: poor attention (Yung et al., 2004); disorganized cognitive 
subscale (Demjaha et al., 2012); interference, perseveration, blockage, and pressure of 
thoughts; disturbances of receptive language (Klosterkotter et al., 2001); and conceptual 
disorganization (Nelson et al., 2013). Supporting the value of including disturbances in both 
thought content and thought processes in defining the high-risk state is a recent study 
(Schultze-Lutter et al., 2014) integrating the Criteria of Psychosis-Risk Syndromes (used in 
this study) and COGDIS criteria, namely, meeting criteria for at least two of nine symptoms 
from a list that includes “unstable ideas of reference” (partially overlapping with P1 and P2) 
and eight symptoms reflecting disturbances of thought processes. Notably, the COGDIS 
items “thought Interference” and “disturbance of receptive speech” partially overlap with 
D3, and items “disturbances of abstract thinking” and “disturbance of receptive speech” 
partially overlap with N5.
It is notable that some symptoms were seldom or never selected (Figure 2). In particular, P4 
(perceptual disturbances) is absent from our risk prediction subscales as it was infrequently 
selected by the greedy algorithm. With two exceptions (Klosterkotter et al., 2001; Mason et 
al., 2004), most other studies have likewise failed to find perceptual disturbances as 
predictive (DeVylder et al., 2014; Katsura et al., 2014; Nelson et al., 2013; Riecher-Rossler 
et al., 2009; Ruhrmann et al., 2010; Salokangas et al., 2013; Thompson et al., 2013; 
Velthorst et al., 2009; Wilcox et al., 2014), including a factor-analysis where a factor 
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including perceptual abnormalities, mood swings/lability, aggression/dangerous behaviors, 
and suicidality/self-harm (symptoms common in personality disorders) was not predictive of 
one-year conversion (Raballo et al., 2011). Psychosis high-risk diagnostic criteria 
(Addington, 2004; Carpenter and Tandon, 2013), including those used in this study, would 
classify a person with perceptual abnormalities alone as high-risk. These findings raise the 
question of whether perceptual disturbances alone should be a diagnostic criteria for a 
clinical high-risk syndrome.
As shown in Figure 3, we found that many models built using pseudo-data had AUCs above 
0.6. Datasets with hidden relationships may show AUCs well above the hypothetical null 
result 0.5 (Rucker et al., 2007). Randomization testing is a way to prove—to a certain p-
value— that the classifier performance in the test set is not unlikely by chance, thus 
facilitating classifier development (Rucker et al., 2007; Tropsha, 2010).
The 2-year conversion in Cohort-2 (16%) is at the low end of rates reported in recent studies 
that range from 15-26% (Demjaha et al., 2012; DeVylder et al., 2014; Katsura et al., 2014; 
Nelson et al., 2013; Ziermans et al., 2011). The calibration slope was similar in both cohorts, 
meaning that, regardless of overall conversion rates, higher scores indicate proportionally 
greater increase in psychosis risk. However calibration-in-the-large was dissimilar between 
cohorts, reflecting in part the higher conversion rate in Cohort-1 than in Cohort-2. Case 
identification strategies may influence the case-mix relative to psychosis risk; for example, 
case identification through screenings of clinic or general populations may yield a broader 
case-mix with lower conversion rates, possibly impacting calibration-in-the-large. The 
emerging risk algorithms, biological or clinical, need to consider calibration before they are 
used to provide absolute estimates of psychosis risk.
In contemporary research settings, the 2-Item and 4-Item subscales might have utility in 
identifying higher-risk subgroups in persons meeting Criteria of Psychosis-Risk Syndromes. 
Considering Cohort-2; with the cutoffs presented in Figure 4d about a third of subjects met 
the severity threshold with a 2-year conversion risk of 30% compared to 9% in the two-third 
subjects identified as at lower risk. At 2-year follow-up, in Cohort-2 the NNT for the 2-Item 
and 4-Item subscales were 5.3 and 4.8, respectively (corresponding to a medium effect size), 
both lower than that of the SOPS Total (NNT=12.5), (corresponding to small effect size) 
(Kraemer and Kupfer, 2006).
Use of risk prediction subscales in clinical settings will require development of strategies to 
educate community mental health care providers about assessment of high-risk symptoms 
and diagnosis of a clinical high-risk state. In addition, discrimination and calibration of the 
risk prediction subscales would need to be evaluated in the hands of trained community 
providers prior to any recommendations about clinical usefulness (Salokangas et al., 2013). 
In particular, calibration and discrimination may differ in community settings. About half of 
persons diagnosed with psychotic disorders have sought mental health care prior to onset of 
psychosis (Rietdijk et al., 2011), and as many as 4-8% of adolescents and young adults 
seeking mental health care may meet clinical high-risk criteria (Ising et al., 2012; Rietdijk et 
al., 2014); it is unclear whether these patient pools are fully represented in psychosis-risk 
research. However, the potential value of symptom-based risk prediction to clinical practice 
Perkins et al. Page 8
Schizophr Res. Author manuscript; available in PMC 2016 December 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
is clear. That potential may be realized when scoring systems are developed that consider 
the personal, social, and financial benefits of treatment (e.g. likelihood of psychosis 
prevention) as well as costs (direct medical costs, side-effects, etc.) (Essock et al., 2002; 
McNeil and Kaij, 1979). Applications of the present work might include treatment 
monitoring, integration with other evaluations, and programs of stepwise application of 
treatments, all in the context of prudent counseling (McGorry et al., 2009).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
CONSORT Diagram of subjects included in Cohort-1 and Cohort-2.
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Figure 2. 
Shown is the quartile plot reflecting the number of times each symptom was chosen for the 
subscale (maximum was 500 times per run) over the 10 runs. Notably, the symptoms P2, P1, 
N5, D3 dominated the choices, implying that all four are somewhat informative of transition 
to psychosis. Other symptoms (e.g. N4) were seldom chosen as informative.
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Figure 3. 
Randomization test results of classifier development using data from Cohort-1 with group 
(converter or nonconverter) randomly re-assigned, with AUC as metric. The histogram was 
fitted accurately with a beta distribution (both Kolmogorov-Smirnov and Anderson-Darling 
α > 0.01). The true classifier as derived with P2, P1, N5, D3 applied to the true data 
achieved AUC = 0.74, having distribution p-value = 3.9E-5. Only once in 1000 trials did a 
pseudo-classifier achieve a higher AUC, implying a nonparametric p-value = 0.002. Note 
that, due to hidden interdependencies in the data, the pseudo-classifiers built with random 
data frequently gave AUCs greater than 0.6, well above the customary and hypothetical 
“random” AUC of 0.5.
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Figure 4. 
Kaplan Meier Survival Curves. For the 2-Item subscale, with a cutoff of 3, there were 80 
(27%) Cohort-1 and 166 (28%) Cohort-2 subjects at “High Risk”. For the 4-Item subscale, 
with a cutoff of 4, there were 98 (33%) Cohort-1 and 193 (33%) Cohort-2 subjects at “High 
Risk”. Shadowed region indicates 95% confidence intervals. AUC (Area Under the Curve of 
the Receiver Operating Characteristic) ranges from 0.5 to 1. The SRD (Success Rate 
Difference) is the difference between survival in the high-risk and low-risk groups, and 
ranges from 0-1. NNT (Number Needed to Take) indicates the number of persons that need 
to be declared as high- and low-risk for one additional true converter to be detected in the 
high-risk group. Black line indicates baseline, gold line indicates Low-Risk, and blue line 
indicates High-Risk Kaplan-Meier (K-M) survival curves.
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Figure 5. 
Calibration curves comparing the observed performance in Cohort 2 with the predicted 
performance of the 2-Item and 4-Item subscales from Cohort-1. Each point represents the 
survival at particular time points (6, 12,18, & 24 months) at a specific cutoff point for the 
subscales (observed scores for the 2-Item subscale ranged from 0-≥5, for the 4-Item subscale 
ranged from 0-≥7). The blue diagonal line indicates perfect calibration. The Pearson 
correlation of values from Cohort-1 and Cohort-2 at each time point is given in the legends.
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Table 1
Demographic characteristics of included and excluded subjects in each cohort.
Cohort-1
Clinical High-Risk
Included
N=296
Cohort-1
Clinical High–Risk,
Excluded
N=81
Cohort-2
Clinical High-Risk
Included
N=592
Cohort-2
Clinical High–Risk,
Excluded
N=151
Mean SD Mean SD Mean SD Mean SD
Age 18.2 4.5 18.3 5.4 18.5 4.3 18.8 4.2
Parental education1 5.4 1.8 4.7 2.0 6.9 1.6 6.6 1.6
Scale of Psychosis-Risk
Symptoms Total
38.9 14.5 36.5 12.6 38.2 12.3 37.1 11.9
2-Item Subscale 2.5 1.7 2.6 1.9 2.6 1.6 2.6 1.6
4-Item Subscale 3.3 2.0 3.2 2.1 3.8 2.0 3.6 2.0
% n % n % n % n
Ancestry,
 Caucasian
 Central/South America
 African
 Asian
 Multiracial
 Other
78.7%
--
9.1%
4.7%
5.1%
2.3%
233
--
27
14
15
7
75.3%
--
8.6%
2.5%
8.6%
4.9%
61
--
7
2
7
4
57.9%
4.1%
15.0%
7.3%
12.5%
3.2%
343
24
89
43
74
17
54.7%
6.0%
16.7%
6.7%
14.0%
1.7%
83
9
25
10
21
3
Sex, male 60% 178 72% 58 58% 54 53% 76
High risk syndrome (not mutually exclusive):
attenuated psychotic
symptoms
96% 284 94% 69 95% 562 94% 142
brief intermittent
psychotic symptoms
3% 9 6.2% 4 3% 18 1% 2
genetic risk and
functional deterioration
13% 38 12% 6 12% 71 9% 18
1
In Cohort-1 included n=215 & excluded n=55; In Cohort-2 included n=585, excluded n=141, SES was significantly lower in persons with no 
follow-up visits to those with at least one follow-up visit, Cohort 1 p-value= 0.02, Cohort-2 p-value=.05
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